Zobrazeno 1 - 5
of 5
pro vyhledávání: '"T. B. Sebree"'
Publikováno v:
Psychopharmacology. 124:168-175
Sertindole is a novel antipsychotic agent with high selectivity for the mesolimbic dopaminergic pathway and nanomolar affinities for dopamine D2, serotonin 5-HT2, and norepinephrine NE alpha 1 receptors. This 40-day randomized, placebo-controlled, do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6169d62e11304d11c114133988325ba4
https://doi.org/10.1007/bf02245618
https://doi.org/10.1007/bf02245618
Autor:
T. Grebb, J. Small, M. Hammer, D. Morris, T. B. Sebree, Joseph P. McEvoy, Herbert Y. Meltzer, D.P. van Kammen, R. Borrison, V. Shu
Publikováno v:
Schizophrenia Research. 9:244
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d15d32bf390a3d5aff34732f623bf7e
https://doi.org/10.1016/0920-9964(93)90548-w
https://doi.org/10.1016/0920-9964(93)90548-w
Autor:
T. B. Sebree, C. M. MacLeod, James T. Doluisio, M. B. Szalkowski, R. S. Geary, Salomon A Stavchansky, R. T. Bachand, R. Heilman
Publikováno v:
Biopharmaceutics & Drug Disposition. 10:229-237
A single-blind study was conducted in 10 healthy male subjects. Each subject was tested with four single oral doses of capsules containing 25, 50, 100, 200mg almitrine bismesylate and one dose of placebo. Blood samples were drawn as a function of tim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84a64289c34f6b2e2f433682fa1b8cde
https://doi.org/10.1002/bdd.2510100302
https://doi.org/10.1002/bdd.2510100302
Autor:
C. M. MacLeod, T. B. Sebree, James T. Doluisio, M. B. Szalkowski, R. S. Geary, R. T. Bachand, Salomon A Stavchansky, R. Heilman
Publikováno v:
Biopharmaceuticsdrug disposition. 10(3)
Bioavailability and bioequivalency studies of almitrine bismesylate from U.S. manufactured film coated, waxed, 50 mg tablets were compared in 34 normal healthy volunteers to 50 mg European film coated, waxed and unwaxed, tablets and a 0.5 per cent (w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6c73d207e8a9d8de45c24ab99e08a6c
https://pubmed.ncbi.nlm.nih.gov/2566338
https://pubmed.ncbi.nlm.nih.gov/2566338
Autor:
T. B. Sebree, R. S. Geary, R. T. Bachand, C. M. MacLeod, Salomon A Stavchansky, James T. Doluisio, R. Heilman, M. B. Szalkowski
Publikováno v:
Biopharmaceuticsdrug disposition. 10(3)
A double blind study utilizing orally administered almitrine bismesylate was conducted involving 36 stable chronic obstructive pulmonary disease (COPD) patients with hypoxia and with and without hypercapnia. The patients received 50 mg tablets twice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53341dbf519c539ea984a38854f2da8d
https://pubmed.ncbi.nlm.nih.gov/2566339
https://pubmed.ncbi.nlm.nih.gov/2566339